(b) The mean SEM data represented the percentage of TNF + cells in different subtypes of T cells indicated for four separate experiments. Moreover, trypsin- and thrombin-induced upregulated expression of TNF was observed MPI-0479605 in CD4+, IL-4+, or CD25+ T cells, but not in IFN+ or IL-17+ T cells. The signaling pathways MAPK/ERK and PI3K/Akt are involved in the thrombin- and trypsin-induced TNF release from T cells. In conclusion, thrombin and trypsin can induce TNF release from IL-4+ and CD25+ T cells through activation of PAR-1 and therefore contribute to regulation of immune response and inflammation of the body. == 1. Introduction == Proteinase-activated receptors (PARs) belong to a family of G-protein-coupled receptors with seven transmembrane domains activated via proteolytic cleavage by serine proteinases [1]. A total of four PARs have been identified and cloned. Among them, PAR-1 [2,3], PAR-3 [4], and PAR-4 [5] are targets for thrombin, trypsin, and cathepsin G, whereas PAR-2 is resistant to thrombin but can be activated by trypsin, mast cell tryptase [6,7], neutrophil elastase [8], and insect-derived proteinase [9]. PARs are expressed by various cells involved in inflammatory and immunological responses, such as vascular endothelial cells, epithelial cells, mast cells, T cells, monocyte, eosinophils, and neutrophils [10,11]. In these cells, activation of PARs affects their main functions such as proliferation, degranulation, and release of inflammatory mediators [10,11]. In our previous study [12], we have showed the expression of PAR-1, PAR-2, and PAR-3 on T cells, and thrombin-, trypsin-, and tryptase-induced interleukin (IL-6) release from T cells. It has also been reported that cytoplasmic free calcium and phospholipase C and protein kinase C activation are increased in T-leukemic cell lines following stimulation with thrombin or the thrombin receptor agonist peptide [13]. Thrombin and thrombin receptor agonist also enhanced CD69 expression and IL-2 productions by cross-linking T cell receptors in both Jurkat T cells and peripheral blood MPI-0479605 lymphocytes [14]. We, therefore, anticipated that thrombin, trypsin, and tryptase might induce TNF release from T cells through PARs. TNF is a major proinflammatory cytokine that is thought to be important in the pathogenesis of asthma [15], food allergy [16], ocular allergy [17], and atopic dermatitis [18]. It has been reported the increased quantity of TNF expressing cells and levels of TNF is definitely observed in the bronchoalveolar lavage (BAL) and in the airways of asthmatics [19]. Inhaled TNF raises airway responsiveness to methacholine in asthmatic subjects associated with a sputum neutrophilia [20]. Since PARs, TNF, and T cells all play tasks in swelling, we believe, there should be some linkages between them. The aim of the present study is definitely to investigate tasks of thrombin, tryptase, trypsin, elastase, and agonist peptides of PARs in the secretion of TNF from purified human being T cells and subtypes of T cells. == 2. Materials and Methods == == 2.1. Reagents == Human being thrombin, trypsin (specific activity:10,000 BAEE U/mg protein), soybean trypsin inhibitor (SBTI), and bovine serum albumin (BSA, portion V) were purchased from Sigma (St Louis, MO, USA). Recombinant hirudin and human being neutrophil elastase (specific activity: 20 MeO-Suc-Ala-Ala-Pro-Val-pNA U/mg protein) were from Calbiochem (San Diego, CA, USA). Recombinant human being Lungtryptase (specific activity:1,000 NCBZ-L-Lysine Thiobenzyl Ester U/mg protein) was from Promega (Madison, WI, USA). SCH 79797 was from Tocris Cookson (Ellisville, Mo, USA). Agonist peptides of PARs, and their reverse forms, and PAR-2 antagonist peptide FSLLRY-NH2were synthesized in CL Bio-Scientific Inc. (Xi An, China). The sequences of the active and reverse peptides were PAR-1, SFLLR-NH2and RLLFS-NH2, TFLLRN-NH2and NRLLFT-NH2; PAR-2, SLIGKV-NH2and VKGILS-NH2as well as trans cinnamoyl (tc)-LIGRLO-NH2and tc-OLRGIL-NH2; PAR-3, TFRGAP-NH2and PAGRFT-NH2. RPMI 1640 and newborn calf serum (NCS) were from GIBCO (Carlsbad, CA, USA). Ficoll-Paque Plus was from Amersham Biosciences (Uppsala, Sweden). PE-conjugated mouse anti-human CD3 monoclonal antibody, PE-conjugated goat-anti rabbit IgG, and TNF OptEIA ELISA packages were purchased from BD PharMingen (San Jose, CA, MPI-0479605 USA). TRIzol reagent and SYBR Green I Stain were purchased from Invitrogen (Carlsbad, CA, USA). MPI-0479605 Cellular activation of signaling packages for extracellular signal-regulated kinase (ERK), 2-(2-diamino)-3-methoxyphenyl-4H-1-benzopyran-4-one (PD98059), Akt, PI3K, and P38 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) was purchased from Cell Signaling Technology (Beverly, MA, USA). ExScript RT reagent kit and SYBRPremix Ex lover Taq(perfect real time) were from TaKaRa (DaLian, China). Rabbit anti-human PAR-1 and rabbit anti-huamn PAR-2 polyclonal MPI-0479605 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). FITC-conjugated mouse anti-human CD4 monoclonal, PE-conjugated mouse anti-human CD8 monoclonal, Percp-cy5.5-conjugated mouse anti-human TNF monoclonal, FITC-conjugated mouse anti-human IFN monoclonal, PE-conjugated Fam162a mouse anti-human IL-4 monoclonal, APC-conjugated mouse anti-human CD25 monoclonal, and APC-conjugated mouse anti-human IL-17 monoclonal antibodies were purchased from eBioscience. Lymphocyte Isolation Kit I had been from Miltenyi Biotec (Bergisch Gladbach, Germany). All other reagents were of analytic grade and from Sigma (St Louis, MO, USA). == 2.2. Isolation and.